These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8417334)

  • 21. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF; Thorgeirsson SS
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.
    Factor VM; Kiss A; Woitach JT; Wirth PJ; Thorgeirsson SS
    J Biol Chem; 1998 Jun; 273(25):15846-53. PubMed ID: 9624185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM; Jensen MR; Thorgeirsson SS
    Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
    Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
    Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression.
    Llorente-Izquierdo C; Mayoral R; Cucarella C; Grau C; Alvarez MS; Flores JM; García-Palencia P; Agra N; Castro-Sánchez L; Boscá L; Martín-Sanz P; Casado M
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():106-15. PubMed ID: 23579063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.
    Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS
    Am J Pathol; 1999 Apr; 154(4):1047-55. PubMed ID: 10233843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.
    Hironaka K; Factor VM; Calvisi DF; Conner EA; Thorgeirsson SS
    Lab Invest; 2003 May; 83(5):643-54. PubMed ID: 12746474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
    Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
    Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.